HEPA - Hepion Pharmaceuticals Inc Stock Price, Fair Value and News

$0.63-0.04 (-5.97%)

Delayed

Max Portfolio Pct.

Check

Valuation

Check

Stock Quality:

Max Portfolio Pct.

Check

Valuation

Check

HEPA Price Action

Last 7 days

-7.3%

Last 30 days

-3.1%

Last 90 days

-14.9%

Trailing 12 Months

-81.5%

HEPA RSI Chart

HEPA Valuation

Market Cap

4.4M

Price/Earnings (Trailing)

-0.19

EV/EBITDA

-0.11

Price/Free Cashflow

-0.18

MarketCap/EBT

-0.17

HEPA Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

HEPA Fundamentals

HEPA Earnings

Earnings (TTM)

-22.7M

Earnings Growth (Yr)

53.78%

Earnings Growth (Qtr)

-23.97%

HEPA Profitability

Return on Equity

5.6K%

Return on Assets

-611.14%

Free Cashflow Yield

-560.42%

HEPA Investor Care

Shares Dilution (1Y)

60.42%

Diluted EPS (TTM)

-4.38

Revenue & Growth

About Hepion Pharmaceuticals Inc

Hepion Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of drug therapy treatment for chronic liver diseases in the United States. It develops Rencofilstat, a cyclophilin inhibitor that has completed Phase 2a clinical trials to target multiple pathologic pathways involved in the progression of liver disease; and is in phase 2 clinical development for the treatment of non-alcoholic steatohepatitis (NASH), as well as preclinical studies of Rencofilstat shows reduction in liver fibrosis, liver inflammation, liver tumor burden, and titers of HBV, HCV, HDV, and HIV-1, and has demonstrated antiviral activities for hepatitis B, C, and D viruses through several mechanisms. The company was formerly known as ContraVir Pharmaceuticals, Inc. and changed its name to Hepion Pharmaceuticals, Inc. in July 2019. Hepion Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Edison, New Jersey.

CEO	Dr. Robert T. Foster B.Sc., BSc (Pharm), Ph.D., Pharm.D.
WEBSITE	hepionpharma.com
SECTOR	Healthcare
INDUSTRY	Biotechnology
EMPLOYEES	25

Hepion Pharmaceuticals Inc Frequently Asked Questions

What is the ticker symbol for Hepion Pharmaceuticals Inc? What does HEPA stand for in stocks?

HEPA is the stock ticker symbol of Hepion Pharmaceuticals Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Hepion Pharmaceuticals Inc (HEPA)?

As of Mon Dec 02 2024, market cap of Hepion Pharmaceuticals Inc is 4.38 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of HEPA stock?

You can check HEPA's fair value in chart for subscribers.

Is Hepion Pharmaceuticals Inc a good stock to buy?

The fair value guage provides a quick view whether HEPA is over valued or under valued. Whether Hepion Pharmaceuticals Inc is cheap or expensive depends on the assumptions which impact Hepion Pharmaceuticals Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for HEPA.

What is 5 year return on Hepion Pharmaceuticals Inc's stock?

In the past 10 years, Hepion Pharmaceuticals Inc has provided -0.639 (multiply by 100 for percentage) rate of return.